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The evaluation and management of young infants
with fever is a common problem and can present
pediatricians with a diagnostic challenge. Infants
with elevated temperatures are at increased risk of
serious bacterial infections (SBI), including bacteremia,
meningitis, urinary tract infections (UTIs), and pneu-
monia [1,2]. Thus, a complete history-taking and
physical examination are required to evaluate young
infants in clinical practice. However, even infants
who appear well may still have SBI [2,3].
Cultures from sterile sites are used as the gold stan-
dard to diagnose occult SBI; however, these results
may not be available in the short term, and efforts
have been made to find a reliable marker for the early
identification of SBI. The ideal screening test should
be able to predict which young infants are at increased
risk of SBI, enabling clinicians to determine the need
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Early diagnosis of serious bacterial infections (SBI) in febrile young infants based on clinical
symptoms and signs is difficult. This study aimed to evaluate the diagnostic values of circulating
chemokines and C-reactive protein (CRP) levels in febrile young infants < 3 months of age with
suspected SBI. We enrolled 43 febrile young infants < 3 months of age with clinically suspected
SBI who were admitted to the neonatal intensive care unit or complete nursing unit of the pedi-
atric department of Kaohsiung Medical University Hospital between December 2006 and July
2007. Blood was drawn from the patients at admission, and complete blood counts, plasma levels
of CRP, granulocyte colony-stimulating factor (G-CSF), and chemokines, including interleukin-8
(IL-8), macrophage inflammatory protein-1α, macrophage inflammatory protein-1β, monokine
induced by interferon-γ, and monocyte chemotactic protein-1 were measured. Patients’ symp-
toms and signs, length of hospital stay, main diagnosis, and results of routine blood tests and
microbiological culture results were recorded. Twenty-six infants (60.5%) were diagnosed with
SBI, while 17 (39.5%) had no evidence of SBI based on the results of bacterial cultures. CRP, IL-8
and G-CSF levels were significantly higher in the infants with SBI than in those without SBI.
Plasma levels of other chemokines were not significantly different between the groups. The area
under the receiver-operating characteristic (ROC) curve for differentiating between the presence
and absence of SBI was 0.79 for CRP level. Diagnostic accuracy was further improved by combin-
ing CRP and IL-8, when the area under the ROC curve increased to 0.91. CRP levels were supe-
rior to IL-8 and G-CSF levels for predicting SBI in febrile infants at initial survey. IL-8 levels could
be used as an additional diagnostic tool in the initial evaluation of febrile young infants, allowing
clinicians to treat these patients more appropriately.
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for further workup and possible antibiotic therapy.
Several methods of evaluation and diagnostic strate-
gies have recently been suggested, but the need for a
screening test remains a source of considerable debate.
Granulocyte colony-stimulating factor (G-CSF) is
a colony-stimulating factor that not only augments
the number of granulocytes, but also activates their
microbicidal activity and inhibits their apoptotic re-
sponse. The potential of G-CSF to enhance the host’s
inflammatory response to infection has been exten-
sively investigated [4]. Chemokines (chemoattractant
cytokines) represent a superfamily of small secreted
proteins that function as intercellular messengers con-
trolling the migration and activation of leukocytes
involved in inflammatory reactions and immunity.
Chemokines and proinflammatory cytokines are es-
sential for initiation of the inflammatory response
and defense against microbial infection [5,6]. Cells in
most inflamed or infected tissues can release a vari-
ety of chemokines, and tissues infected with different
bacteria release chemokines that recruit immune cells
to sites of inflammation. Hence, chemokines play im-
portant roles at various stages throughout the infec-
tious process [6,7].
The aim of this study was to evaluate and compare
the diagnostic values of circulating levels of G-CSF
and various potential chemokines for the early diag-
nosis of SBI in young febrile infants < 3 months of age.
PATIENTS AND METHODS
Ethical approval
The study was approved by the Human Experiment
and Ethics Committee of Kaohsiung Medical Uni-
versity Hospital and informed consent was obtained
from the parents of all patients before enrolment.
Patients
Febrile young infants < 3 months of age with clini-
cally suspected SBI who were admitted to the neona-
tal intensive care unit or complete nursing unit of the
pediatric department of Kaohsiung Medical Univer-
sity Hospital between December 2006 and July 2007
were enrolled. The infants were suspected of having
SBI if they had at least one of the following signs or
symptoms: tachypnea, dyspnea, tachycardia, brady-
cardia, reduced activity, lethargy, or decreased appe-
tite. Diagnostic work-up, including bacterial cultures,
was performed to identify or rule out bacterial infec-
tion. Antibiotic therapy was prescribed for all en-
rolled patients at admission. Blood was collected at
admission for the measurement of complete blood
counts, C-reactive protein (CRP), and plasma chemo-
kine levels. All infants included in the study were
admitted to our hospital from the community; noso-
comially infected infants were excluded.
SBI was defined as bacterial pathogens isolated
from the cerebrospinal fluid or blood, a UTI, or pneu-
monia. Pneumonia was diagnosed by the presence of
related clinical symptoms, such as tachypnea or a pro-
ductive cough, along with a positive finding on chest
X-ray. A UTI was diagnosed as pyuria and two sets of
urine cultures with a single pathogen growth of >104
colony forming units/mL from a bladder catheteriza-
tion, or >105 colony forming units/mL collected from a
sterile collection bag [8]. The absolute neutrophil counts
(ANC) and immature neutrophils/total neutrophils (IT
ratio) were calculated according to the white blood cell
(WBC) differential counts. The medical records of all
patients with positive cerebrospinal fluid, blood, or
urine cultures were thoroughly reviewed.
Measurement of CRP and circulating
chemokine levels in plasma
Blood samples were collected in EDTA tubes at admis-
sion, and centrifuged immediately. The plasma samples
for CRP levels were analyzed using rate turbidimetry
(SYNCHRON® System(s)), Beckman Coulter Ireland
Inc., Galway, Ireland). Plasma was frozen at –80°C until
analysis of chemokines. Human Chemokines 6plex
FlowCytomix Multiplex assay (Bender MedSystems
GmbH, Vienna, Austria) was used according to the
manufacturer’s instructions to measure circulating lev-
els of G-CSF and chemokines, including interleukin-8
(IL-8), macrophage inflammatory protein-1α (MIP-
1α), macrophage inflammatory protein-1β (MIP-1β),
monokine induced by interferon-γ (MIG), and mono-
cyte chemotactic protein-1 (MCP-1). This assay requires
a 25-μL serum sample. The standard ranges for this
assay were: G-CSF, 34.3–25,000 pg/mL; IL-8, 13.7–
10,000 pg/mL; MCP-1, 41.2–30,000 pg/mL; MIG, 6.9–
5,000 pg/mL; MIP-1α, 13.7–10,000 pg/mL; and MIP-
1β, 4.1–3,000 pg/mL.
Statistical analysis
Data entry and statistical analysis were performed
using SPSS version 11.5 (SPSS Inc., Chicago, IL, USA).
Both median and range were calculated for continu-
ous data. Variables were tested for their association
with the diagnosis using χ2 tests for categorical data
and Mann-Whitney U tests for numerical data. The
diagnostic values of the different variables and the
best cutoff values were determined using receiver-
operating characteristic (ROC) curves. Sensitivity,
specificity, and positive and negative predictive val-
ues were calculated for the cutoff points that repre-
sented the best discrimination, as derived from the
areas under the ROC curves. Correlations between
chemokine levels and biological features or clinical
outcomes were assessed using Spearman’s correla-
tion tests. A two-tailed p value < 0.05 was considered
statistically significant.
RESULTS
Forty-three febrile infants < 3 months of age who were
admitted to the pediatric department of Kaohsiung
Medical University Hospital were enrolled in this
study. A total of 26 infants (60.5%) were diagnosed
with SBI, while 17 (39.5%) had no evidence of SBI,
based on the results of bacterial cultures. The charac-
teristics and clinical findings of these two groups are
shown in Table 1. There were no differences in sex or
age between the two groups. Significantly greater
percentages of infants with SBI had respiratory dis-
tress symptoms (tachypnea, chest retraction, cyanosis,
nasal flaring, or grunting) and gastrointestinal symp-
toms (decrease of appetite, vomiting, or diarrhea),
compared with infants without SBI. There were no
differences between the groups in terms of vital signs
recorded at admission, including body temperature,
pulse rate, and respiratory rate. The causes of SBI
included two cases of pneumonia (one with positive
urine group B streptococcal antigen test), three cases
of sepsis (Escherichia coli, Salmonella spp. and oxacillin-
resistant Staphylococcus epidermidis), and 21 cases of
UTIs. E. coli was the most frequent causative organ-
ism of UTIs (n = 15, 71.4%). Proteus mirabilis (n = 3)
and Enterococcus faecalis (n = 3) were also identified.
The laboratory tests at initial evaluation (Table 2)
revealed no significant differences between the two
groups in terms of total WBC counts, ANC, IT ratios,
hemoglobin, or platelet counts. CRP, IL-8, and G-CSF
levels, however, were significantly higher in infants
with SBI. Levels of other plasma chemokines, such as
MIP-1α, MIP-1β, MIG, and MCP-1 were comparable
between the groups.
The sensitivity, specificity, positive predictive
value, negative predictive value, and the best cutoff
values of CRP, IL-8, and G-CSF based on ROC anal-
ysis are presented in Table 3. The diagnostic proper-
ties of CRP, IL-8, and G-CSF levels were compared 
by calculating the areas under the ROC curves. The
areas under the ROC curves for differentiating be-
tween the presence and absence of SBI were 0.79 (95%
CI, 0.65–0.92) for CRP levels, 0.71 (95% CI, 0.56–0.86)
for IL-8 levels, and 0.68 (95% CI, 0.52–0.84) for G-CSF
(Table 3). CRP with a cutoff value of 13.6 μg/mL had
a better diagnostic accuracy than IL-8 or G-CSF levels
for predicting febrile infants with SBI at initial sur-
vey. Diagnostic accuracy was further improved by
combining CRP with either IL-8 or G-CSF, for which
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Table 1. Clinical characteristics of febrile infants with and without serious bacterial infections (SBI) at admission*
Infants with SBI (n = 26) Infants without SBI (n = 17) p
Age (d) 52 (1–90) 38 (4–90) 0.822
Sex (male:female) 20:6 11:6 0.383
Respiratory distress symptoms† (%) 26.9 0 0.019
Gastrointestinal symptoms and signs‡ (%) 53.8 23.5 0.049
Vital signs at admission
Body temperature (°C) 37 (36.4–39.3) 37 (36.7–38.7) 0.410
Pulse rate (/min) 150 (126–181) 152 (130–195) 0.390
Respiratory rate (/min) 46 (26–136) 49 (30–58) 0.275
Length of hospital stay (d) 8 (5–30) 7 (2–10) 0.058
*Continuous data presented as median (range); †including tachypnea, chest retraction, or cyanosis; ‡including decrease of appetite,
vomiting, or diarrhea.
the areas under ROC curves were increased to 0.91
and 0.81, respectively (Table 3; Figure).
There was positive correlation between IL-8 levels
and the length of hospital stay (Spearman’s correlation
coefficient=0.419, p=0.005). No correlation was found
between levels of CRP or other chemokines and clin-
ical outcome. There were no correlations between
chemokine levels, CRP levels, total WBC count, ANC,
IT ratio, and microbial species.
DISCUSSION
In this study, we simultaneously evaluated levels of
CRP, G-CSF and several chemokines (MIP-1α, IL-8,
MIP-1β, MIG, and MCP-1), and demonstrated that
CRP had the best specificity and sensitivity for pre-
dicting SBI in febrile infants < 3 months of age. How-
ever, the combinations of CRP with IL-8 or G-CSF
were superior to CRP alone for the early prediction of
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Table 2. Laboratory variables of febrile infants with and without serious bacterial infections (SBI) at admission*
Infants with SBI (n = 26) Infants without SBI (n = 17) p
Corrected WBC count (/mm3) 11,785 (4,620–22,000) 11,450 (4,250–21,590) 0.364
Absolute neutrophil count (/mm3) 5,216 (1,010–16,280) 3,925 (1,110–11,010) 0.190
IT ratio 0 (0–0.43) 0 (0–0.12) 0.867
Hemoglobin (g/dL) 11.2 (8.7–21.6) 11.9 (9.3–16.5) 0.804
Platelet count (× 103/mm3) 383 (190–895) 337 (205–683) 0.233
CRP (μg/mL) 14.7 (0–153.7) 1.7 (0–13.6) 0.002
Chemokines
G-CSF (pg/mL) 15.6 (0–992.7) 0 (0–298.8) 0.032
IL-8 (pg/mL) 0 (0–4,745.7) 0 (0–0) 0.002
MIP-1α (pg/mL) 138.8 (0–7,307.9) 0 (0–974.8) 0.229
MIP-1β (pg/mL) 88.6 (0–2,343.8) 69.3 (0–189.6) 0.235
MCP-1 (pg/mL) 912.8 (0–10,310.4) 1,087.7 (0–9,595) 0.803
MIG (pg/mL) 242.6 (0–1,620.2) 253.1 (0–938.2) 0.566
*Continuous data presented as median (range). WBC = white blood cell; IT ratio = immature neutrophils/total neutrophils; CRP =
C-reactive protein; G-CSF=granulocyte colony-stimulating factor; IL-8= interleukin-8; MIP-1α=macrophage inflammatory protein-1α;
MIP-1β = macrophage inflammatory protein-1β; MCP-1 = monocyte chemotactic protein-1; MIG = monokine induced by interferon-γ.
Table 3. Diagnostic accuracy of CRP, IL-8 and G-CSF levels in febrile infants with serious bacterial infections at 
admission*
Test result variables 
Positive Negative 
Area under the
Sensitivity (%) Specificity (%) predictive predictive 
ROC curve(best cutoff value)
value value
CRP (≥ 13.6 μg/mL) 58 (43–73) 100 1.0 0.61 0.79 (0.65–0.92)
(0.46–0.75)
G-CSF (≥ 50.8 pg/mL) 46 (31–63) 88 (77–99) 0.86 0.52 0.68 (0.52–0.84)
(0.75–0.96) (0.37–0.67)
IL-8 (≥ 59.7 pg/mL) 42 (28–57) 100 1.0 0.53 0.71 (0.56–0.86)
(0.38–0.68)
CRP ≥ 13.6 μg/mL and/or 73 (60–86) 88 (77–99) 0.90 0.68 0.81 (0.67–0.94)
G-CSF ≥ 50.8 pg/mL (0.82–0.99) (0.54–0.82)
CRP ≥ 13.6 μg/mL and/or 77 (64–90) 100 1.0 0.74 0.91 (0.78–0.99)
IL-8 ≥ 59.7 pg/mL (0.61–0.87)
*95% confidence intervals presented in the parentheses. CRP = C-reactive protein; IL-8 = interleukin-8; G-CSF = granulocyte colony-
stimulating factor; ROC = receiver-operating characteristic.
SBI in these infants. MIP-1α, MIP-1β, MIG, and MCP-1
levels, however, could not be used to differentiate
between SBI and non-SBI diseases in febrile young
infants.
Early identification and management of SBI in fe-
brile young infants is needed due to the less effective
defense system of young infants and the high mor-
bidity associated with SBI [2]. Unfortunately, however,
there are currently no reportedly reliable clinical
symptoms, signs, or laboratory tests suitable for the
early diagnosis of SBI in these patients. Bacterial cul-
tures provide the gold standard procedure for detect-
ing occult SBI, but the results of this procedure are
not promptly available. Efforts to find a reliable
marker for the early identification of SBI are therefore
ongoing.
Total WBC count, ANC, and immature neutrophil
levels are the common tests used for screening SBI in
clinical settings. These tests, however, are not always
able to distinguish between bacterial infections and
respiratory viral infections in young febrile children
[9–12], as shown in the current study. CRP has recently
become the most commonly used marker for both the
early recognition of clinically undetectable SBI and
an indicator of the need for further management.
CRP concentration has been reported to be both more
sensitive and more specific than either total WBC
count or ANC [13–15]. Although CRP demonstrated
good diagnostic accuracy in this study, previous 
reports have found CRP to be an unsatisfactory marker
for identifying young infants with SBI [16–18]. A sin-
gle CRP measurement cannot be used to definitively
diagnose SBI [18].
Chemokines have recently become a focus of inter-
est for inflammation and infection research. Chemo-
kines play a major role in diseases with an accentuated
inflammatory component, and have been found at
similar levels in the serum of neonates and adults
[19–22]. Among the various chemokines, IL-8 is pro-
duced predominantly by monocytes, macrophages,
and endothelial cells in response to various stimuli,
such as lipopolysaccharide and tumor necrosis factor-α
[23]. This chemokine is one of the major mediators of
the inflammatory response. IL-8 plays an important
role in the release, activation, and chemotaxis of neu-
trophils. Several studies have shown that serum IL-8
levels are increased in newborns with culture-proven
sepsis [24–29]. Kurt et al and Kocabas et al also
reported that plasma IL-8 levels were higher in septic
than in non-septic newborn infants [24,26]. We also
found a positive correlation between IL-8 levels and
the length of hospital stay. This suggests that IL-8
could serve as a predictor of disease outcome, but not
as a good indicator of SBI. However, we found that
levels of IL-8 and G-CSF, a factor influencing neu-
trophil function, were significantly increased in the
SBI group and showed high specificity for differenti-
ating bacterial infection in febrile infants.
CRP, IL-8, and G-CSF alone demonstrated moder-
ate accuracies (areas under the ROC curves 0.7–0.9)
for diagnosing SBI in febrile infants. However, the
accuracy was improved (area under the ROC curve
> 0.9) by combining IL-8 and CRP values. This result
implies that CRP and IL-8 levels could serve as indi-
cators for the early prescription of antibiotics.
In conclusion, these results demonstrate that CRP
levels are superior to IL-8 and G-CSF levels for pre-
dicting SBI in febrile infants at initial survey. The
combination of the inflammatory marker IL-8 with
CRP could improve the sensitivity and specificity of
SBI detection in febrile young infants, thus allowing
clinicians to treat these patients more appropriately.
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for detecting serious bacterial infections in febrile infants.
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嚴重細菌感染之發燒嬰兒的細胞趨化激素濃度表現
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在小於 3 個月以下的發燒小嬰兒，以病人臨床表現及現有之實驗室檢查都不足以完全
預測有無嚴重細菌感染 (serious bacterial infection, SBI) 。本研究的目的是評估血
中的顆粒球生長激素 (GCSF)、細胞趨化激素 (chemokines)及 C反應蛋白 (CRP)，
在小於 3 個月大之發燒嬰兒鑑別嚴重細菌感染之診斷能力。研究對象為年齡小於 3 個
月的發燒嬰兒，因臨床上懷疑有嚴重細菌感染，在 2006 年 12 月至 2007 年 7 月間，
住入高雄醫學大學附設醫院小兒科新生兒加護病房或中重度病房的病人。在入院時抽
血測一般血液檢查、CRP、G-CSF及細胞趨化激素濃度，並作血液、尿液或腦脊髓液
細菌培養。細胞趨化激素的測定內容包括 interleukin-8 (IL-8) ，macrophage 
inflammatory protein-1α，macrophage inflammatory protein-1β，
monokine induced by interferon-γ，and monocyte chemotactic protein-1。
病人依細菌培養之結果將病人分成 SBI及 non-SBI兩組來比較各類變項。結果共有 
43 位小於 3個月的發燒嬰兒納入本研究，SBI組共有 26 位 (60.5%)，而 non-SBI組
共有 17 位 (39.5%)。統計分析顯示 CRP、GCSF及 IL-8在 SBI組比起 non-SBI組
有顯著的上升。而其他細胞趨化激素則在兩組中無顯著差異。以 CRP的診斷能力而
言，其 receiver-operating characteristic (ROC) 曲線下面積可達 0.79。若將 CRP
與 IL-8合併來看，則更可提高對於 SBI的診斷率，在ROC曲線下面積可增至 0.91。
我們的結論是 CRP在早期鑑別小於 3 個月的發燒嬰兒有無細菌性感染，優於 IL-8與
GCSF。但在初步評估發燒嬰兒上，IL-8可作為 CRP以外的輔助診斷工具，以使臨
床醫師在處置發燒嬰兒時可提早及時使用抗生素。
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